Role of inflammatory cytokines in induction of anterior chamber-associated immune deviation

Ocular Immunology and Inflammation

Volumn 6, Issue 1, 1998, Pages 1-11

  Okamoto, Shigeki ^a   Streilein, J Wayne ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

ACAID; Antigen presenting cells; Proinflammatory cytokines; TGF

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL;

EID: 0031778814     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.6.1.1.8081     Document Type: Article

References (25)

1. Streilein JW. Tissue barriers, immunosuppressive microenviromments, and privileged sites: the eye's point of view. Reg Immunol 1993; 5:253-268.
2. Wilbanks UH, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 1991; 146:3018-3024.
3. Wilbanks GH, Streilein JW. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg Immunol 1992; 4:130-137.
4. Sy M-S, Miller SD, Kowach HW, Claman HM. A splenic requirement for generation of suppressor T cells. J Immunol 1997; 119:2095-2102.
5. Kaplan HJ, Streilein JW. Do immunologically privileged sites require a functioning spleen? Nature 1974; 251:553-554.
6. Streilein JW, Niederkorn JY. Induction of anterior chamber associated immune deviation requires an intact, functional spleen. J Exp Med 1981; 153:1058-1067.
7. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber associated immune deviation (ACAID). I. Evidence that an antigen-specific. ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol 1991; 146:2610-2617.
8. Williamson JSP, Bradley D, Streilein JW. Immunoregulatory properties of hone marrow-derived cells in the iris and ciliary body. Immunology 1989; 67:96-102.
9. Granstein R, Stszewski R, Knisely T, Zeira E, Nazareno R, Latina M, Albert D. Aqueous humor contains transforming growth factor-β and a small (<3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990; 144:3021-3027.
10. Cousins S, McCabe M, Danielpour R, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991; 32:2201-2211.
11. Jampel HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-b in human aqueous humor. Curr Eye Res 1990; 9:963-969.
12. Wahlestedt C, Beding B, Ekman R, Oksala O, Stjernschantz J, Hakanson R. Calcitonin gene-related peptide in the eye: release by sensory nerve stimulation and effects associated with neurogenic inflammation. Regul Pept 1986; 16: 107-115.
13. Wilbanks GA, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta. Eur J Immunol 1992; 22:1031-1036.
14. Williamson JSP, DiMarco S, Streilein JW. Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation. Invest Ophthalmol Vis Sci 1987; 28:1527-1532.
15. Williamson JSP, Streilein JW. Induction of delayed hypersensitivity to alloantigens co-injected with Langerhans cells into the anterior chamber of the eye: abrogation of ACAID. Transplantation 1989; 47:519-523.
16. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci 1996; 36:2176-2185.
17. McLeish W, Rubsamen P, Atherton SS, Streilein JW. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice. Reg Immunol 1989; 2(4)1236-243.
18. Benson JL, Niederkorn JY. Interleukin-1 abrogates anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 1990; 31(10):2123-2138.
19. Niederkorn JY. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation. Transplantation 1987; 43(4):523-528.
20. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol 1992; 1:165-173.
21. Virgin HW 4th, Wittenberg GF, Bancroft GJ, Unanue ER. Suppression of immune response to Listeria monocytogenes: mechanism(s) of immune complex suppression. Infect Immun 1985; 50(2):343-353.
22. Cousins SW, Trattler WB, Streilein JW. Immune privilege and suppression of immunogenic inflammation in the anterior chamber of the eye. Curr Eye Res 1991; 10:287-297.
23. Streilein JW, Cousins S, Bradley D. Effect of intraocular gamma-interferon on immunoregulatory properties of iris and ciliary body cells. Invest Ophthalmol Vis Sci 1990; 31:2304-2315.
24. Geiger K, Sarvetnick N. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J Immunol 1994; 153(11):5239-5246.
25. Yoshikawa T, Streilein JW. Cisurocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol 1992; 148(10):3072-3078.